{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T09:43:07Z","timestamp":1762854187687,"version":"build-2065373602"},"reference-count":154,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,21]],"date-time":"2021-08-21T00:00:00Z","timestamp":1629504000000},"content-version":"am","delay-in-days":354,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 &amp; S\u00e9nologie\u00a0"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.gofs.2020.05.007","type":"journal-article","created":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T22:43:30Z","timestamp":1589582610000},"page":"629-645","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Tumeurs fronti\u00e8res de l\u2019ovaire. Recommandations pour la pratique clinique du CNGOF\u00a0\u2013\u00a0Biopathologie des tumeurs fronti\u00e8res de l\u2019ovaire"],"prefix":"10.1016","volume":"48","author":[{"given":"C.","family":"Eymerit-Morin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.L.","family":"Brun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Vabret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Devouassoux-Shisheboran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8\u00a0Suppl. 2","key":"10.1016\/j.gofs.2020.05.007_bib0005","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/S0368-2315(10)70026-0","article-title":"[Methods and organization]","volume":"39","author":"Fauconnier","year":"2010","journal-title":"J Gynecol Obstet Biol Reprod (Paris)"},{"year":"2014","series-title":"WHO classification of tumours of female reproductive organs","key":"10.1016\/j.gofs.2020.05.007_bib0010"},{"issue":"2","key":"10.1016\/j.gofs.2020.05.007_bib0015","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00428-016-2040-8","article-title":"Ovarian borderline tumors in the 2014\u00a0WHO classification: evolving concepts and diagnostic criteria","volume":"470","author":"Hauptmann","year":"2017","journal-title":"Virchows Arch"},{"issue":"8","key":"10.1016\/j.gofs.2020.05.007_bib0020","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.humpath.2004.03.004","article-title":"Borderline ovarian tumors: diverse contemporary viewpoints on terminology and diagnostic criteria with illustrative images","volume":"35","author":"Seidman","year":"2004","journal-title":"Hum Pathol"},{"issue":"8","key":"10.1016\/j.gofs.2020.05.007_bib0025","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.humpath.2004.03.003","article-title":"Borderline ovarian tumors: key points and workshop summary","volume":"35","author":"Silverberg","year":"2004","journal-title":"Hum Pathol"},{"issue":"Suppl. 2","key":"10.1016\/j.gofs.2020.05.007_bib0030","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1016\/S0893-3952(22)04457-X","article-title":"Borderline epithelial tumors of the ovary","volume":"18","author":"Hart","year":"2005","journal-title":"Mod Pathol"},{"issue":"9\u00a0Suppl. 3","key":"10.1016\/j.gofs.2020.05.007_bib0035","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1097\/IGC.0000000000000282","article-title":"Gynecologic Cancer InterGroup (GCIG) consensus review for ovarian tumors of low malignant potential (borderline ovarian tumors)","volume":"24","author":"Harter","year":"2014","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"10.1016\/j.gofs.2020.05.007_bib0040","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.1016\/S1470-2045(11)70288-1","article-title":"Borderline ovarian tumour: pathological diagnostic dilemma and risk factors for invasive or lethal recurrence","volume":"13","author":"Morice","year":"2012","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.1016\/j.gofs.2020.05.007_bib0045","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1097\/CCO.0b013e32833b0dc1","article-title":"The pathology of and controversial aspects of ovarian borderline tumours","volume":"22","author":"McCluggage","year":"2010","journal-title":"Curr Opin Oncol"},{"issue":"4","key":"10.1016\/j.gofs.2020.05.007_bib0050","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1053\/beog.2002.0300","article-title":"Pathology of borderline (low malignant potential) ovarian tumours","author":"Seidman","year":"2002","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.gofs.2020.05.007_bib1005","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/annonc\/mdz062","article-title":"ESMO-ESGO consensus conference recommendations on ovarian cancer: Pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease","volume":"30","author":"Colombo","year":"2019","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1016\/j.gofs.2020.05.007_bib0060","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1097\/00000478-200404000-00009","article-title":"Grading ovarian serous carcinoma using a two-tier system","volume":"28","author":"Malpica","year":"2004","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"10.1016\/j.gofs.2020.05.007_bib0065","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.humpath.2004.03.005","article-title":"Serous borderline (low malignant potential, atypical proliferative) ovarian tumors: workshop perspectives","volume":"35","author":"Bell","year":"2004","journal-title":"Hum Pathol"},{"issue":"5","key":"10.1016\/j.gofs.2020.05.007_bib0070","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/S0002-9440(10)63708-X","article-title":"Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis","volume":"164","author":"Shih","year":"2004","journal-title":"Am J Pathol"},{"issue":"2","key":"10.1016\/j.gofs.2020.05.007_bib0075","first-page":"151","article-title":"Pathogenesis of ovarian cancer: lessons from morphology and molecular biology and their clinical implications","volume":"27","author":"Kurman","year":"2008","journal-title":"Int J Gynecol Pathol"},{"issue":"2","key":"10.1016\/j.gofs.2020.05.007_bib0080","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/01.pas.0000146025.91953.8d","article-title":"Patterns of p53\u00a0mutations separate ovarian serous borderline tumors and low- and high-grade carcinomas and provide support for a new model of ovarian carcinogenesis: a mutational analysis with immunohistochemical correlation","volume":"29","author":"Singer","year":"2005","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.gofs.2020.05.007_bib0085","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1097\/PAS.0000000000000824","article-title":"Long-term behavior of serous borderline tumors subdivided into atypical proliferative tumors and noninvasive low-grade carcinomas: a population-based clinicopathologic study of 942\u00a0cases","volume":"41","author":"Vang","year":"2017","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"10.1016\/j.gofs.2020.05.007_bib0090","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1097\/PAS.0000000000000693","article-title":"Low-grade serous carcinoma of the ovary: clinicopathologic analysis of 52\u00a0invasive cases and identification of a possible noninvasive intermediate lesion","volume":"40","author":"Ahn","year":"2016","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.gofs.2020.05.007_bib0095","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/01.pas.0000164030.82810.db","article-title":"Ovarian serous tumors of low malignant potential (borderline tumors): outcome-based study of 276\u00a0patients with long-term (>or=5-year) follow-up","volume":"29","author":"Longacre","year":"2005","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"10.1016\/j.gofs.2020.05.007_bib0100","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1097\/00000478-199611000-00003","article-title":"Micropapillary serous carcinoma of the ovary. A distinctive low-grade carcinoma related to serous borderline tumors","volume":"20","author":"Burks","year":"1996","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"10.1016\/j.gofs.2020.05.007_bib0105","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1097\/00000478-199611000-00004","article-title":"Subclassification of serous borderline tumors of the ovary into benign and malignant types. A clinicopathologic study of 65\u00a0advanced stage cases","volume":"20","author":"Seidman","year":"1996","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.gofs.2020.05.007_bib0110","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/00000478-199904000-00004","article-title":"Ovarian serous borderline tumors with micropapillary and cribriform patterns: a study of 40\u00a0cases and comparison with 44\u00a0cases without these patterns","volume":"23","author":"Eichhorn","year":"1999","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.gofs.2020.05.007_bib0115","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/1471-0528.13840","article-title":"Serous and mucinous borderline ovarian tumours: differences in clinical presentation, high-risk histopathological features, and lethal recurrence rates","volume":"123","author":"Vasconcelos","year":"2016","journal-title":"BJOG"},{"issue":"5","key":"10.1016\/j.gofs.2020.05.007_bib0120","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1053\/hp.2000.8048","article-title":"Ovarian serous borderline tumors: a critical review of the literature with emphasis on prognostic indicators","volume":"31","author":"Seidman","year":"2000","journal-title":"Hum Pathol"},{"issue":"9","key":"10.1016\/j.gofs.2020.05.007_bib0125","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1097\/00000478-200209000-00002","article-title":"Serous borderline tumors of the ovary: a long-term follow-up study of 137\u00a0cases, including 18\u00a0with a micropapillary pattern and 20\u00a0with microinvasion","volume":"26","author":"Prat","year":"2002","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.gofs.2020.05.007_bib0130","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.ygyno.2011.08.008","article-title":"Micropapillary pattern in serous borderline ovarian tumors: does it matter?","volume":"123","author":"Park","year":"2011","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.gofs.2020.05.007_bib0135","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ygyno.2014.06.002","article-title":"A nationwide study of serous \u201cborderline\u201d ovarian tumors in Denmark 1978\u20132002: centralized pathology review and overall survival compared with the general population","volume":"134","author":"Hannibal","year":"2014","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.gofs.2020.05.007_bib0140","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.ygyno.2010.11.016","article-title":"Risk factors for recurrence of ovarian borderline tumors","volume":"120","author":"Shih","year":"2011","journal-title":"Gynecol Oncol"},{"issue":"9","key":"10.1016\/j.gofs.2020.05.007_bib0145","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1097\/00000478-200209000-00003","article-title":"Micropapillary and cribriform patterns in ovarian serous tumors of low malignant potential: a study of 99\u00a0advanced stage cases","volume":"26","author":"Deavers","year":"2002","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.gofs.2020.05.007_bib0150","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1097\/PAS.0000000000000155","article-title":"Evaluation of microinvasion and lymph node involvement in ovarian serous borderline\/atypical proliferative serous tumors: a morphologic and immunohistochemical analysis of 37\u00a0cases","volume":"38","author":"Maniar","year":"2014","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.gofs.2020.05.007_bib0155","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.ygyno.2012.10.013","article-title":"Quantification of ER\/PR expression in ovarian low-grade serous carcinoma","volume":"128","author":"Escobar","year":"2013","journal-title":"Gynecol Oncol"},{"issue":"5","key":"10.1016\/j.gofs.2020.05.007_bib0160","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/PAS.0b013e3181da7687","article-title":"PAX8\u00a0reliably distinguishes ovarian serous tumors from malignant mesothelioma","volume":"34","author":"Laury","year":"2010","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.gofs.2020.05.007_bib0165","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/PAP.0b013e318234aaed","article-title":"WT1\u00a0expression in the female genital tract","volume":"18","author":"B\u00e1rcena","year":"2011","journal-title":"Adv Anat Pathol"},{"issue":"6","key":"10.1016\/j.gofs.2020.05.007_bib0170","first-page":"407","article-title":"Serous tumor of low malignant potential with early stromal invasion (serous LMP with microinvasion)","volume":"1","author":"Tavassoli","year":"1988","journal-title":"Mod Pathol"},{"issue":"4","key":"10.1016\/j.gofs.2020.05.007_bib0175","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0046-8177(90)90201-F","article-title":"Ovarian serous borderline tumors with stromal microinvasion: a report of 21\u00a0cases","volume":"21","author":"Bell","year":"1990","journal-title":"Hum Pathol"},{"issue":"6","key":"10.1016\/j.gofs.2020.05.007_bib0180","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/00000478-199206000-00005","article-title":"Ovarian serous tumors of low malignant potential (serous borderline tumors). The relationship of exophytic surface tumor to peritoneal \u201cimplants\u201d","volume":"16","author":"Segal","year":"1992","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"10.1016\/j.gofs.2020.05.007_bib0185","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1016\/j.ejca.2013.01.035","article-title":"Borderline tumours of the ovary: a cohort study of the Arbeitsgmeinschaft Gyn\u00e4kologische Onkologie (AGO) Study Group","volume":"49","author":"du Bois","year":"2013","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.gofs.2020.05.007_bib0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijgo.2013.10.001","article-title":"Staging classification for cancer of the ovary, fallopian tube, and peritoneum","volume":"124","author":"Prat","year":"2014","journal-title":"Int J Gynaecol Obstet"},{"issue":"1","key":"10.1016\/j.gofs.2020.05.007_bib0195","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/AOG.0000000000000917","article-title":"Staging classification for cancer of the ovary, fallopian tube, and peritoneum: abridged republication of guidelines from the International Federation of Gynecology and Obstetrics (FIGO)","volume":"126","author":"Prat","year":"2015","journal-title":"Obstet Gynecol"},{"issue":"10","key":"10.1016\/j.gofs.2020.05.007_bib0200","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1002\/1097-0142(19881115)62:10<2212::AID-CNCR2820621024>3.0.CO;2-W","article-title":"Peritoneal implants of ovarian serous borderline tumors. Histologic features and prognosis","volume":"62","author":"Bell","year":"1988","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.gofs.2020.05.007_bib0205","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1097\/PAS.0000000000000692","article-title":"Classification of extraovarian implants in patients with ovarian serous borderline tumors (tumors of low malignant potential) based on clinical outcome","volume":"40","author":"McKenney","year":"2016","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.gofs.2020.05.007_bib0210","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1002\/(SICI)1097-0142(19980315)82:6<1096::AID-CNCR13>3.0.CO;2-1","article-title":"Ovarian serous borderline tumors with invasive peritoneal implants","volume":"82","author":"Gershenson","year":"1998","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.gofs.2020.05.007_bib0215","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1093\/annonc\/mdg173","article-title":"Prognostic factors for patients with advanced stage serous borderline tumours of the ovary","volume":"14","author":"Morice","year":"2003","journal-title":"Ann Oncol"},{"issue":"5","key":"10.1016\/j.gofs.2020.05.007_bib0220","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1097\/01.pas.0000194743.33540.e6","article-title":"Lymph node involvement in ovarian serous tumors of low malignant potential (borderline tumors): pathology, prognosis, and proposed classification","volume":"30","author":"McKenney","year":"2006","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.gofs.2020.05.007_bib0225","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/00004347-200210000-00009","article-title":"Cytokeratins 7\u00a0and 20, Dpc4, and MUC5AC in the distinction of metastatic mucinous carcinomas in the ovary from primary ovarian mucinous tumors: Dpc4\u00a0assists in identifying metastatic pancreatic carcinomas","volume":"21","author":"Ji","year":"2002","journal-title":"Int J Gynecol Pathol"},{"issue":"5","key":"10.1016\/j.gofs.2020.05.007_bib0230","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1440-1827.2005.01819.x","article-title":"Diagnostic challenge of secondary (metastatic) ovarian tumors simulating primary endometrioid and mucinous neoplasms","volume":"55","author":"Hart","year":"2005","journal-title":"Pathol Int"},{"issue":"8","key":"10.1016\/j.gofs.2020.05.007_bib0235","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1440-1827.1996.tb03656.x","article-title":"Clinicopathologic and mucin histochemical analyses of 90\u00a0cases of ovarian mucinous borderline tumors of intestinal and m\u00fcllerian types","volume":"46","author":"Nomura","year":"1996","journal-title":"Pathol Int"},{"issue":"7","key":"10.1016\/j.gofs.2020.05.007_bib0240","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1097\/00000478-200307000-00014","article-title":"Primary and metastatic mucinous adenocarcinomas in the ovaries: incidence in routine practice with a new approach to improve intraoperative diagnosis","volume":"27","author":"Seidman","year":"2003","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"10.1016\/j.gofs.2020.05.007_bib0245","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1097\/00000478-200011000-00001","article-title":"Mucinous tumors of the ovary: a clinicopathologic study of 196\u00a0borderline tumors (of intestinal type) and carcinomas, including an evaluation of 11\u00a0cases with \u201cpseudomyxoma peritonei\u201d","volume":"24","author":"Lee","year":"2000","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.gofs.2020.05.007_bib0250","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/0046-8177(95)90247-3","article-title":"Pseudomyxoma peritonei in women: a clinicopathologic analysis of 30\u00a0cases with emphasis on site of origin, prognosis, and relationship to ovarian mucinous tumors of low malignant potential","volume":"26","author":"Ronnett","year":"1995","journal-title":"Hum Pathol"},{"issue":"5","key":"10.1016\/j.gofs.2020.05.007_bib0255","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.pap.0000213038.85704.e4","article-title":"From krukenberg to today: the ever present problems posed by metastatic tumors in the ovary: part I. Historical perspective, general principles, mucinous tumors including the Krukenberg tumor","volume":"13","author":"Young","year":"2006","journal-title":"Adv Anat Pathol"},{"issue":"3","key":"10.1016\/j.gofs.2020.05.007_bib0260","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/PAP.0b013e3180504abf","article-title":"From Krukenberg to today: the ever present problems posed by metastatic tumors in the ovary. Part II","volume":"14","author":"Young","year":"2007","journal-title":"Adv Anat Pathol"},{"issue":"1","key":"10.1016\/j.gofs.2020.05.007_bib0265","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/modpathol.3800510","article-title":"Immunohistochemistry for estrogen and progesterone receptors in the distinction of primary and metastatic mucinous tumors in the ovary: an analysis of 124\u00a0cases","volume":"19","author":"Vang","year":"2006","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.gofs.2020.05.007_bib0270","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/01.pgp.0000177125.31046.fd","article-title":"Ovarian atypical proliferative (borderline) mucinous tumors: gastrointestinal and seromucinous (endocervical-like) types are immunophenotypically distinctive","volume":"25","author":"Vang","year":"2006","journal-title":"Int J Gynecol Pathol"},{"issue":"9","key":"10.1016\/j.gofs.2020.05.007_bib0275","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.pas.0000213281.43036.bb","article-title":"Cytokeratins 7\u00a0and 20\u00a0in primary and secondary mucinous tumors of the ovary: analysis of coordinate immunohistochemical expression profiles and staining distribution in 179\u00a0cases","volume":"30","author":"Vang","year":"2006","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"10.1016\/j.gofs.2020.05.007_bib0280","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1038\/modpathol.3800698","article-title":"Immunohistochemical expression of CDX2\u00a0in primary ovarian mucinous tumors and metastatic mucinous carcinomas involving the ovary: comparison with CK20\u00a0and correlation with coordinate expression of CK7","volume":"19","author":"Vang","year":"2006","journal-title":"Mod Pathol"},{"issue":"6","key":"10.1016\/j.gofs.2020.05.007_bib0285","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1097\/PAS.0b013e318216c112","article-title":"A comprehensive analysis of PAX8\u00a0expression in human epithelial tumors","volume":"35","author":"Laury","year":"2011","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.gofs.2020.05.007_bib0290","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/path.4088","article-title":"Molecular characterization of mucinous ovarian tumours supports a stratified treatment approach with HER2\u00a0targeting in 19\u00a0% of carcinomas","volume":"229","author":"Anglesio","year":"2013","journal-title":"J Pathol"},{"issue":"6","key":"10.1016\/j.gofs.2020.05.007_bib0295","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1097\/PAS.0b013e31802efb45","volume":"31","author":"Vang","year":"2007","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"10.1016\/j.gofs.2020.05.007_bib0300","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1038\/modpathol.2008.107","article-title":"Cadherin-17\u00a0is a useful diagnostic marker for adenocarcinomas of the digestive system","volume":"21","author":"Su","year":"2008","journal-title":"Mod Pathol"},{"issue":"3","key":"10.1016\/j.gofs.2020.05.007_bib0305","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/01.pas.0000149708.12335.6a","article-title":"Immunohistochemical staining in the diagnosis of pancreatobiliary and ampulla of Vater adenocarcinoma: application of CDX2, CK17, MUC1, and MUC2","volume":"29","author":"Chu","year":"2005","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.gofs.2020.05.007_bib0310","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/01.pgp.0000101141.31270.a0","article-title":"The value of Cdx2\u00a0immunostaining in differentiating primary ovarian carcinomas from colonic carcinomas metastatic to the ovaries","volume":"23","author":"Groisman","year":"2004","journal-title":"Int J Gynecol Pathol"},{"issue":"2","key":"10.1016\/j.gofs.2020.05.007_bib0315","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1046\/j.1365-2559.2003.01687.x","article-title":"Differentiation of ovarian mucinous carcinoma and metastatic colorectal adenocarcinoma by immunostaining with beta-catenin","volume":"43","author":"Chou","year":"2003","journal-title":"Histopathology"},{"issue":"8","key":"10.1016\/j.gofs.2020.05.007_bib0320","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/S0046-8177(03)00268-5","article-title":"Expression of alpha-methylacyl-CoA racemase (P504s) in various malignant neoplasms and normal tissues: a study of 761\u00a0cases","volume":"34","author":"Jiang","year":"2003","journal-title":"Hum Pathol"},{"issue":"7","key":"10.1016\/j.gofs.2020.05.007_bib0325","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1136\/jclinpath-2011-200162","article-title":"Pathology of primary and metastatic mucinous ovarian neoplasms","volume":"65","author":"Leen","year":"2012","journal-title":"J Clin Pathol"},{"issue":"7","key":"10.1016\/j.gofs.2020.05.007_bib0330","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1136\/jcp.2010.085688","article-title":"Immunohistochemistry in the distinction between primary and metastatic ovarian mucinous neoplasms","volume":"65","author":"McCluggage","year":"2012","journal-title":"J Clin Pathol"},{"issue":"1","key":"10.1016\/j.gofs.2020.05.007_bib0335","doi-asserted-by":"crossref","first-page":"39","DOI":"10.5858\/arpa.2014-0057-RA","article-title":"The utility of immunohistochemistry in the differential diagnosis of gynecologic disorders","volume":"139","author":"Kaspar","year":"2015","journal-title":"Arch Pathol Lab Med"},{"issue":"8","key":"10.1016\/j.gofs.2020.05.007_bib0340","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.humpath.2004.03.006","article-title":"Mucinous borderline ovarian tumors: points of general agreement and persistent controversies regarding nomenclature, diagnostic criteria, and behavior","volume":"35","author":"Ronnett","year":"2004","journal-title":"Hum Pathol"},{"issue":"3","key":"10.1016\/j.gofs.2020.05.007_bib0345","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/PGP.0b013e3181fcf01a","article-title":"Mucinous tumor of low malignant potential (\u201cborderline\u201d or \u201catypical proliferative\u201d tumor) of the ovary: a study of 171\u00a0cases with the assessment of intraepithelial carcinoma and microinvasion","volume":"30","author":"Khunamornpong","year":"2011","journal-title":"Int J Gynecol Pathol"},{"issue":"6","key":"10.1016\/j.gofs.2020.05.007_bib0350","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1097\/00000478-199906000-00001","article-title":"Evaluation of diagnostic criteria and behavior of ovarian intestinal type mucinous tumors: atypical proliferative (borderline) tumors and intraepithelial, microinvasive, invasive, and metastatic carcinomas","volume":"23","author":"Riopel","year":"1999","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.gofs.2020.05.007_bib0355","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00000478-200202000-00001","article-title":"Mucinous tumors of the ovary: a clinicopathologic analysis of 75\u00a0borderline tumors (of intestinal type) and carcinomas","volume":"26","author":"Rodr\u00edguez","year":"2002","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.gofs.2020.05.007_bib0360","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1097\/01.pas.0000213430.68998.2c","article-title":"Is stromal microinvasion in primary mucinous ovarian tumors with \u201cmucin granuloma\u201d true invasion?","volume":"31","author":"Kim","year":"2007","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.gofs.2020.05.007_bib0365","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/PAS.0b013e3181451b93","article-title":"Anaplastic carcinoma in mucinous ovarian tumors: a clinicopathologic study of 34\u00a0cases emphasizing the crucial impact of stage on prognosis, their histologic spectrum, and overlap with sarcomalike mural nodules","volume":"32","author":"Provenza","year":"2008","journal-title":"Am J Surg Pathol"},{"issue":"12","key":"10.1016\/j.gofs.2020.05.007_bib0370","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1016\/j.humpath.2014.08.003","article-title":"Ovarian Brenner tumors and Walthard nests: a histologic and immunohistochemical study","volume":"45","author":"Roma","year":"2014","journal-title":"Hum Pathol"},{"issue":"11","key":"10.1016\/j.gofs.2020.05.007_bib0375","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1097\/00000478-200311000-00005","article-title":"Immunoprofile of ovarian tumors with putative transitional cell (urothelial) differentiation using novel urothelial markers: histogenetic and diagnostic implications","volume":"27","author":"Logani","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.gofs.2020.05.007_bib0380","first-page":"179","article-title":"Transitional cell carcinoma and other transitional cell tumors of the ovary","volume":"1","author":"Roth","year":"1996","journal-title":"Anat Pathol"},{"issue":"4","key":"10.1016\/j.gofs.2020.05.007_bib0385","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1097\/PAS.0b013e318188b84c","article-title":"Transitional cell tumors of the ovary: a comparative clinicopathologic, immunohistochemical, and molecular genetic analysis of Brenner tumors and transitional cell carcinomas","volume":"33","author":"Cuatrecasas","year":"2009","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"10.1016\/j.gofs.2020.05.007_bib0390","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1097\/IGC.0b013e318267db2f","article-title":"Management and prognosis of borderline ovarian Brenner tumors","volume":"22","author":"Uzan","year":"2012","journal-title":"Int J Gynecol Cancer"},{"issue":"11","key":"10.1016\/j.gofs.2020.05.007_bib0395","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.5858\/132.11.1753","article-title":"Exploring the histogenesis of ovarian mucinous and transitional cell (Brenner) neoplasms and their relationship with Walthard cell nests: a study of 120\u00a0tumors","volume":"132","author":"Seidman","year":"2008","journal-title":"Arch Pathol Lab Med"},{"issue":"7","key":"10.1016\/j.gofs.2020.05.007_bib0400","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1097\/PAS.0000000000000405","article-title":"Ovarian seromucinous carcinoma: report of a series of a newly categorized and uncommon neoplasm","volume":"39","author":"Taylor","year":"2015","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"10.1016\/j.gofs.2020.05.007_bib0405","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1097\/01.pas.0000138178.10829.b8","article-title":"Endocervical-like mucinous borderline tumors of the ovary: a clinicopathologic analysis of 31\u00a0cases","volume":"28","author":"Rodriguez","year":"2004","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.gofs.2020.05.007_bib0410","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1097\/PAS.0000000000000812","article-title":"Morphologic reproducibility, genotyping, and immunohistochemical profiling do not support a category of seromucinous carcinoma of the ovary","volume":"41","author":"Rambau","year":"2017","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.gofs.2020.05.007_bib0415","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s00795-003-0221-4","article-title":"Endocervical-like mucinous borderline tumors of the ovary: clinicopathological features and electron microscopic findings","volume":"36","author":"Moriya","year":"2003","journal-title":"Med Electron Microsc"},{"issue":"1","key":"10.1016\/j.gofs.2020.05.007_bib0420","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/PGP.0000000000000266","article-title":"Seromucinous tumors of the ovary. What's in a name?","volume":"35","author":"Kurman","year":"2016","journal-title":"Int J Gynecol Pathol"},{"issue":"12","key":"10.1016\/j.gofs.2020.05.007_bib0425","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1097\/00000478-200212000-00001","article-title":"Diagnostic criteria and behavior of ovarian seromucinous (endocervical-type mucinous and mixed cell-type) tumors: atypical proliferative (borderline) tumors, intraepithelial, microinvasive, and invasive carcinomas","volume":"26","author":"Shappell","year":"2002","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"10.1016\/j.gofs.2020.05.007_bib0430","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.humpath.2008.12.006","article-title":"Immunohistochemical characterization of mullerian mucinous borderline tumors: possible histogenetic link with serous borderline tumors and low-grade endometrioid tumors","volume":"40","author":"Yasunaga","year":"2009","journal-title":"Hum Pathol"},{"issue":"11","key":"10.1016\/j.gofs.2020.05.007_bib0435","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1097\/00000478-200011000-00002","article-title":"A clinicopathologic analysis of atypical proliferative (borderline) tumors and well-differentiated endometrioid adenocarcinomas of the ovary","volume":"24","author":"Bell","year":"2000","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"10.1016\/j.gofs.2020.05.007_bib0440","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1097\/00000478-200309000-00009","article-title":"Ovarian endometrioid tumors of low malignant potential: a clinicopathologic study of 30\u00a0cases with comparison to well-differentiated endometrioid adenocarcinoma","volume":"27","author":"Roth","year":"2003","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.gofs.2020.05.007_bib0445","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1097\/01.pas.0000213369.71676.25","article-title":"p16\u00a0expression in primary ovarian mucinous and endometrioid tumors and metastatic adenocarcinomas in the ovary: utility for identification of metastatic HPV-related endocervical adenocarcinomas","volume":"31","author":"Vang","year":"2007","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.gofs.2020.05.007_bib0450","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.suronc.2012.02.002","article-title":"Management and prognosis of endometrioid borderline tumors of the ovary","volume":"21","author":"Uzan","year":"2012","journal-title":"Surg Oncol"},{"issue":"2","key":"10.1016\/j.gofs.2020.05.007_bib0455","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/01.pas.0000213355.72638.f4","article-title":"Comparative analysis of alternative and traditional immunohistochemical markers for the distinction of ovarian sertoli cell tumor from endometrioid tumors and carcinoid tumor: a study of 160\u00a0cases","volume":"31","author":"Zhao","year":"2007","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"10.1016\/j.gofs.2020.05.007_bib0460","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1097\/PAS.0000000000000298","article-title":"The histomorphology of Lynch syndrome-associated ovarian carcinomas: toward a subtype-specific screening strategy","volume":"38","author":"Chui","year":"2014","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.gofs.2020.05.007_bib0465","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1002\/1097-0142(19840301)53:5<1156::AID-CNCR2820530522>3.0.CO;2-2","article-title":"Ovarian clear cell adenofibromatous tumors. Benign, of low malignant potential, and associated with invasive clear cell carcinoma","volume":"53","author":"Roth","year":"1984","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.gofs.2020.05.007_bib0470","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1002\/1097-0142(19851215)56:12<2922::AID-CNCR2820561233>3.0.CO;2-L","article-title":"Benign and borderline clear cell adenofibromas of the ovary","volume":"56","author":"Bell","year":"1985","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.gofs.2020.05.007_bib0475","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/modpathol.2010.75","article-title":"Alternate mucoid and hyalinized stroma in clear cell carcinoma of the ovary: manifestation of serial stromal remodeling","volume":"23","author":"Kato","year":"2010","journal-title":"Mod Pathol"},{"issue":"3","key":"10.1016\/j.gofs.2020.05.007_bib0480","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.ygyno.2018.07.003","article-title":"Inter-pathologist and pathology report agreement for ovarian tumor characteristics in the Nurses\u2019 Health Studies","volume":"150","author":"Barnard","year":"2018","journal-title":"Gynecol Oncol"},{"issue":"9","key":"10.1016\/j.gofs.2020.05.007_bib0485","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/S0046-8177(88)80082-0","article-title":"Observer variation in histologic classification of malignant and borderline ovarian tumors","volume":"19","author":"Stalsberg","year":"1988","journal-title":"Hum Pathol"},{"issue":"4","key":"10.1016\/j.gofs.2020.05.007_bib0490","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/PGP.0000000000000342","article-title":"Value of pathology review in a population-based series of ovarian tumors","volume":"36","author":"Stewart","year":"2017","journal-title":"Int J Gynecol Pathol"},{"issue":"3","key":"10.1016\/j.gofs.2020.05.007_bib0495","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ygyno.2009.02.010","article-title":"Clinicopathological characteristics of mucinous adenocarcinoma of the ovary","volume":"113","author":"Shimada","year":"2009","journal-title":"Gynecol Oncol"},{"year":"2019","series-title":"R\u00e9f\u00e9rentiel de l\u2019observatoire des tumeurs rares gyn\u00e9cologiques\u00a0: les tumeurs ovariennes borderline","key":"10.1016\/j.gofs.2020.05.007_bib0500"},{"issue":"2","key":"10.1016\/j.gofs.2020.05.007_bib0505","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0090-8258(90)90050-U","article-title":"Histologic sampling requirements in ovarian carcinoma: a review of 51\u00a0tumors","volume":"38","author":"Gramlich","year":"1990","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.gofs.2020.05.007_bib0510","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/PGP.0000000000000566","article-title":"Intratumoral heterogeneity accounts for apparent progression of noninvasive serous tumors to invasive low-grade serous carcinoma: a study of 30\u00a0low-grade serous tumors of the ovary in 18\u00a0patients with peritoneal carcinomatosis","volume":"39","author":"Seidman","year":"2020","journal-title":"Int J Gynecol Pathol"},{"issue":"5","key":"10.1016\/j.gofs.2020.05.007_bib0515","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1002\/1097-0142(197305)31:5<1031::AID-CNCR2820310501>3.0.CO;2-7","article-title":"Borderline and malignant mucinous tumors of the ovary. Histologic criteria and clinical behavior","volume":"31","author":"Hart","year":"1973","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.gofs.2020.05.007_bib0520","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1097\/00000478-199812000-00002","article-title":"Primary ovarian mucinous cystadenocarcinomas: a clinicopathologic study of 49\u00a0cases with long-term follow-up","volume":"22","author":"Hoerl","year":"1998","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"10.1016\/j.gofs.2020.05.007_bib0525","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/modpathol.2015.77","article-title":"Data set for reporting of ovary, fallopian tube and primary peritoneal carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR)","volume":"28","author":"McCluggage","year":"2015","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.gofs.2020.05.007_bib0530","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1136\/ijgc-00009577-200601000-00006","article-title":"Sampling the omentum in ovarian neoplasia: when one block is enough","volume":"16","author":"Doig","year":"2006","journal-title":"Int J Gynecol Cancer"},{"issue":"10","key":"10.1016\/j.gofs.2020.05.007_bib0535","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.5858\/2007-131-1578-OFGCHM","article-title":"Omentectomy for gynecologic cancer: how much sampling is adequate for microscopic examination?","volume":"131","author":"Usub\u00fct\u00fcn","year":"2007","journal-title":"Arch Pathol Lab Med"},{"issue":"3","key":"10.1016\/j.gofs.2020.05.007_bib0540","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/PGP.0000000000000148","article-title":"Optimal sampling of grossly normal omentum in staging of gynecologic malignancies","volume":"34","author":"Skala","year":"2015","journal-title":"Int J Gynecol Pathol"},{"issue":"5","key":"10.1016\/j.gofs.2020.05.007_bib0545","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1097\/IGC.0000000000000140","article-title":"The value of random biopsies, omentectomy, and hysterectomy in operations for borderline ovarian tumors","volume":"24","author":"Kristensen","year":"2014","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.gofs.2020.05.007_bib0550","first-page":"CD010360","article-title":"Intraoperative frozen section analysis for the diagnosis of early stage ovarian cancer in suspicious pelvic masses","volume":"3","author":"Ratnavelu","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"16","key":"10.1016\/j.gofs.2020.05.007_bib0555","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.7150\/jca.25883","article-title":"Diagnostic accuracy of frozen section analysis of borderline ovarian tumors: a meta-analysis with emphasis on misdiagnosis factors","volume":"9","author":"Huang","year":"2018","journal-title":"J Cancer"},{"issue":"12","key":"10.1016\/j.gofs.2020.05.007_bib0560","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1007\/s00330-006-0163-z","article-title":"MR imaging compared with intraoperative frozen section examination for the diagnosis of adnexal tumors; correlation with final histology","volume":"16","author":"Bazot","year":"2006","journal-title":"Eur Radiol"},{"issue":"3","key":"10.1016\/j.gofs.2020.05.007_bib0565","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2008.04.002","article-title":"Factors influencing the use and accuracy of frozen section diagnosis of epithelial ovarian tumors","volume":"199","author":"Brun","year":"2008","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.gofs.2020.05.007_bib0570","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/j.1471-0528.2011.03129.x","article-title":"Intraoperative frozen section analysis for suspected early stage ovarian cancer: 11\u00a0years of Gateshead Cancer Centre experience","volume":"119","author":"Cross","year":"2012","journal-title":"BJOG"},{"issue":"4","key":"10.1016\/j.gofs.2020.05.007_bib0575","first-page":"737","article-title":"Accuracy of intraoperative frozen sections in the diagnosis of ovarian masses","volume":"9","author":"Suprasert","year":"2008","journal-title":"Asian Pac J Cancer Prev"},{"issue":"4","key":"10.1016\/j.gofs.2020.05.007_bib0580","first-page":"245","article-title":"Potential role of increasing number of sections in frozen section diagnosis of ovarian tumors","volume":"11","author":"Ayhan","year":"2016","journal-title":"J Exp Ther Oncol"},{"issue":"1","key":"10.1016\/j.gofs.2020.05.007_bib0585","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jmig.2018.04.005","article-title":"Accuracy of intraoperative frozen section diagnosis of borderline ovarian tumors by hospital type","volume":"26","author":"Shah","year":"2019","journal-title":"J Minim Invasive Gynecol"},{"issue":"1","key":"10.1016\/j.gofs.2020.05.007_bib0590","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/igc.0000000000001150","article-title":"An evaluation of frozen section and lymph node dissection results for mucinous ovarian tumors","volume":"28","author":"Moroney","year":"2018","journal-title":"Int J Gynecol Cancer"},{"issue":"6","key":"10.1016\/j.gofs.2020.05.007_bib0595","first-page":"657","article-title":"Intraoperative assessment of epithelial and non-epithelial ovarian tumors: a 7-year review","volume":"30","author":"Pavlakis","year":"2009","journal-title":"Eur J Gynaecol Oncol"},{"issue":"5","key":"10.1016\/j.gofs.2020.05.007_bib0600","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3109\/01443615.2012.683212","article-title":"Accuracy of frozen section in the diagnosis of ovarian tumours","volume":"32","author":"Toneva","year":"2012","journal-title":"J Obstet Gynaecol"},{"issue":"2","key":"10.1016\/j.gofs.2020.05.007_bib0605","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00404-008-0899-6","article-title":"Accuracy of frozen section diagnosis in ovarian masses: experience at a tertiary oncology center","volume":"280","author":"Rakhshan","year":"2009","journal-title":"Arch Gynecol Obstet"},{"issue":"1","key":"10.1016\/j.gofs.2020.05.007_bib0610","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ygyno.2011.06.030","article-title":"Frozen section diagnoses of 578\u00a0ovarian tumors made by pathologists with and without expertise on gynecologic pathology","volume":"123","author":"Bige","year":"2011","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.gofs.2020.05.007_bib0615","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1006\/gyno.1995.0004","article-title":"The accuracy of a frozen section diagnosis of borderline ovarian malignancy","volume":"59","author":"Menzin","year":"1995","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.gofs.2020.05.007_bib0620","first-page":"216","article-title":"Intraoperative assessment of ovarian tumors: a 5-year review with assessment of discrepant diagnostic cases","volume":"25","author":"Stewart","year":"2006","journal-title":"Int J Gynecol Pathol"},{"issue":"5","key":"10.1016\/j.gofs.2020.05.007_bib0625","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1159\/000449362","article-title":"Fine needle aspiration biopsies of ovarian masses: a reliable technique","volume":"60","author":"Mokhatri","year":"2016","journal-title":"Acta Cytol"},{"issue":"6","key":"10.1016\/j.gofs.2020.05.007_bib0630","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/PGP.0000000000000199","article-title":"Diagnosis of ovarian carcinoma histotype based on limited sampling: a prospective study comparing cytology, frozen section, and core biopsies to full pathologic examination","volume":"34","author":"Hoang","year":"2015","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.gofs.2020.05.007_bib0635","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ejogrb.2014.10.012","article-title":"Management of presumed benign ovarian tumors: updated French guidelines","volume":"183","author":"Brun","year":"2014","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"5","key":"10.1016\/j.gofs.2020.05.007_bib0640","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/cncr.9045","article-title":"Cytologic identification of serous neoplasms in peritoneal fluids","volume":"93","author":"Weir","year":"2001","journal-title":"Cancer"},{"issue":"931","key":"10.1016\/j.gofs.2020.05.007_bib0645","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1136\/pmj.79.931.292","article-title":"How valuable is ascitic cytology in the detection and management of malignancy?","volume":"79","author":"Karoo","year":"2003","journal-title":"Postgrad Med J"},{"issue":"4","key":"10.1016\/j.gofs.2020.05.007_bib0650","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/00000478-200104000-00001","article-title":"Refined diagnostic criteria for implants associated with ovarian atypical proliferative serous tumors (borderline) and micropapillary serous carcinomas","volume":"25","author":"Bell","year":"2001","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"10.1016\/j.gofs.2020.05.007_bib0655","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1038\/modpathol.2013.55","article-title":"The diagnostic utility of TP53\u00a0and CDKN2A to distinguish ovarian high-grade serous carcinoma from low-grade serous ovarian tumors","volume":"26","author":"Altman","year":"2013","journal-title":"Mod Pathol"},{"issue":"11","key":"10.1016\/j.gofs.2020.05.007_bib0660","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.5858\/arpa.2013-0691-RA","article-title":"A review of preanalytical factors affecting molecular, protein, and morphological analysis of formalin-fixed, paraffin-embedded (FFPE) tissue: how well do you know your FFPE specimen?","volume":"138","author":"Bass","year":"2014","journal-title":"Arch Pathol Lab Med"},{"issue":"2","key":"10.1016\/j.gofs.2020.05.007_bib0665","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.18632\/oncotarget.13691","article-title":"Robust detection of immune transcripts in FFPE samples using targeted RNA-sequencing","volume":"8","author":"Paluch","year":"2017","journal-title":"Oncotarget"},{"issue":"7","key":"10.1016\/j.gofs.2020.05.007_bib0670","doi-asserted-by":"crossref","first-page":"e0127353","DOI":"10.1371\/journal.pone.0127353","article-title":"Robustness of next generation sequencing on older formalin-fixed paraffin-embedded tissue","volume":"10","author":"Carrick","year":"2015","journal-title":"PLoS ONE"},{"issue":"4","key":"10.1016\/j.gofs.2020.05.007_bib0675","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/PDM.0b013e318169bfaf","article-title":"Assessing the impact of tissue devitalization time on genome-wide gene expression analysis in ovarian tumor samples","volume":"17","author":"Dumur","year":"2008","journal-title":"Diagn Mol Pathol"},{"issue":"2","key":"10.1016\/j.gofs.2020.05.007_bib0680","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s00428-007-0529-x","article-title":"Tissue transfer to pathology labs: under vacuum is the safe alternative to formalin","volume":"452","author":"Bussolati","year":"2008","journal-title":"Virchows Arch"},{"issue":"2","key":"10.1016\/j.gofs.2020.05.007_bib0685","first-page":"155","volume":"47","author":"Devouassoux-Shisheboran","year":"2019","journal-title":"Gynecol Obstet Fertil Senol"},{"issue":"1","key":"10.1016\/j.gofs.2020.05.007_bib0690","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1186\/s12885-017-3585-x","article-title":"Association between tumour infiltrating lymphocytes, histotype and clinical outcome in epithelial ovarian cancer","volume":"17","author":"James","year":"2017","journal-title":"BMC Cancer"},{"issue":"2","key":"10.1016\/j.gofs.2020.05.007_bib0695","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ygyno.2011.09.039","article-title":"Prognostic significance of tumor-infiltrating T cells in ovarian cancer: a meta-analysis","volume":"124","author":"Hwang","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.gofs.2020.05.007_bib0700","first-page":"639","article-title":"Ovarian cancer in BRCA1\u00a0and BRCA2\u00a0gene mutation carriers: analysis of prognostic factors and survival","volume":"10","author":"Biglia","year":"2016","journal-title":"Ecancer Med Sci"},{"issue":"12","key":"10.1016\/j.gofs.2020.05.007_bib0705","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1002\/cncr.21536","article-title":"BRCA1\u00a0and BRCA2\u00a0mutations account for a large proportion of ovarian carcinoma cases","volume":"104","author":"Pal","year":"2005","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.gofs.2020.05.007_bib0710","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1007\/s12094-008-0267-9","article-title":"Risk-reduction surgery in BRCA mutation carriers in a Spanish population: adherence and results","volume":"10","author":"P\u00e9rez Segura","year":"2008","journal-title":"Clin Transl Oncol"},{"issue":"22","key":"10.1016\/j.gofs.2020.05.007_bib0715","doi-asserted-by":"crossref","first-page":"7569","DOI":"10.1158\/1078-0432.CCR-08-0112","article-title":"High-risk for ovarian cancer in a prospective series is restricted to BRCA1\/2\u00a0mutation carriers","volume":"14","author":"Maehle","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.gofs.2020.05.007_bib0720","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ejca.2016.10.006","article-title":"Current perspectives on recommendations for BRCA genetic testing in ovarian cancer patients","volume":"69","author":"Vergote","year":"2016","journal-title":"Eur J Cancer"},{"issue":"19","key":"10.1016\/j.gofs.2020.05.007_bib0725","doi-asserted-by":"crossref","first-page":"6915","DOI":"10.1158\/0008-5472.CAN-04-2067","article-title":"Mutations of BRAF and KRAS precede the development of ovarian serous borderline tumors","volume":"64","author":"Ho","year":"2004","journal-title":"Cancer Res"},{"issue":"6","key":"10.1016\/j.gofs.2020.05.007_bib0730","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/labinvest.3700103","article-title":"Molecular genetic analysis of ovarian serous cystadenomas","volume":"84","author":"Cheng","year":"2004","journal-title":"Lab Invest"},{"issue":"Suppl. 1","key":"10.1016\/j.gofs.2020.05.007_bib0735","doi-asserted-by":"crossref","first-page":"i16","DOI":"10.1093\/annonc\/mdw089","article-title":"The molecular pathology of ovarian serous borderline tumors","volume":"27","author":"Malpica","year":"2016","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.gofs.2020.05.007_bib0740","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/cncr.27782","article-title":"BRAF mutation is associated with early stage disease and improved outcome in patients with low-grade serous ovarian cancer","volume":"119","author":"Grisham","year":"2013","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.gofs.2020.05.007_bib0745","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/path.4252","article-title":"KRAS (but not BRAF) mutations in ovarian serous borderline tumour are associated with recurrent low-grade serous carcinoma","volume":"231","author":"Tsang","year":"2013","journal-title":"J Pathol"},{"issue":"2","key":"10.1016\/j.gofs.2020.05.007_bib0750","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/modpathol.2017.121","article-title":"KRAS mutation of extraovarian implants of serous borderline tumor: prognostic indicator for adverse clinical outcome","volume":"31","author":"Zuo","year":"2018","journal-title":"Mod Pathol"},{"issue":"2","key":"10.1016\/j.gofs.2020.05.007_bib0755","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.pathol.2017.12.001","article-title":"Prognostic indicators in ovarian serous borderline tumours","volume":"50","author":"Malpica","year":"2018","journal-title":"Pathology"},{"issue":"4","key":"10.1016\/j.gofs.2020.05.007_bib0760","first-page":"174","article-title":"Immunohistochemical analysis of hMLH1\u00a0and hMSH2\u00a0proteins in serous ovarian tumours","volume":"60","author":"Stasikowska-Kanicka","year":"2009","journal-title":"Pol J Pathol"},{"issue":"5","key":"10.1016\/j.gofs.2020.05.007_bib0765","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1097\/PGP.0000000000000087","article-title":"Endometrioid adenocarcinoma of the ovary mimicking serous borderline tumor: report of a series of cases","volume":"33","author":"Mansor","year":"2014","journal-title":"Int J Gynecol Pathol"},{"issue":"2\u20133","key":"10.1016\/j.gofs.2020.05.007_bib0770","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1159\/000443176","article-title":"Functional assessment of synoptic pathology reporting for ovarian cancer","volume":"83","author":"S\u0142odkowska","year":"2016","journal-title":"Pathobiology"}],"container-title":["Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 &amp; S\u00e9nologie\u00a0"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468718920301872?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468718920301872?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T09:39:08Z","timestamp":1762853948000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468718920301872"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":154,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S2468718920301872"],"URL":"https:\/\/doi.org\/10.1016\/j.gofs.2020.05.007","relation":{},"ISSN":["2468-7189"],"issn-type":[{"type":"print","value":"2468-7189"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumeurs fronti\u00e8res de l\u2019ovaire. Recommandations pour la pratique clinique du CNGOF\u00a0\u2013\u00a0Biopathologie des tumeurs fronti\u00e8res de l\u2019ovaire","name":"articletitle","label":"Article Title"},{"value":"Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie\u00a0","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gofs.2020.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.gofs.2020.01.014","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.gofs.2020.01.016","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.gofs.2020.01.015","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.gofs.2020.01.022","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.gofs.2020.01.023","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.gofs.2020.01.018","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.gofs.2020.01.012","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.gofs.2020.01.019","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.gofs.2020.01.021","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.gofs.2020.01.013","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.gofs.2020.01.017","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.gofs.2020.01.020","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}